Study: Anti-obesity drug aids weight loss without heart risks

08/30/2011 | Reuters

Forty percent of 4,000 obese adults who took Arena Pharmaceuticals's lorcaserin drug for a year lost at least 5% of their body weight compared with 25% in the placebo group who lost as much, according to a study in the Journal of Clinical Endocrinology and Metabolism. The drug didn't increase the risk of heart-valve damage, but it may not reach the market due to concerns about a potential cancer risk.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Food & Drug Associate
Washington, D.C., DC
Senior Manager, Gaps in Care
UAW Retiree Medical Benefits Trust
Detroit, MI
Compliance Director
Abbott Laboratories
Santa Clara, CA
Product Development Manager, Disposable Medical Products
ASAHI INTECC, Orange County CA R&D Center
Santa Ana, CA
Neurovascular Intervention Product Sales Rep, North East
Multiple Locations, SL_Multiple Locations